• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dcf1 缺失可减少淀粉样β 聚集并减轻记忆缺陷。

Deletion of Dcf1 Reduces Amyloid-β Aggregation and Mitigates Memory Deficits.

机构信息

Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, Shanghai, China.

出版信息

J Alzheimers Dis. 2021;81(3):1181-1194. doi: 10.3233/JAD-200619.

DOI:10.3233/JAD-200619
PMID:33896839
Abstract

BACKGROUND

Alzheimer's disease (AD) is a progressive neurodegenerative disease. One of the pathologies of AD is the accumulation of amyloid-β (Aβ) to form senile plaques, leading to a decline in cognitive ability and a lack of learning and memory. However, the cause leading to Aβ aggregation is not well understood. Dendritic cell factor 1 (Dcf1) shows a high expression in the entorhinal cortex neurons and neurofibrillary tangles in AD patients.

OBJECTIVE

Our goal is to investigate the effect of Dcf1 on Aβ aggregation and memory deficits in AD development.

METHODS

The mouse and Drosophila AD model were used to test the expression and aggregation of Aβ, senile plaque formation, and pathological changes in cognitive behavior during dcf1 knockout and expression. We finally explored possible drug target effects through intracerebroventricular delivery of Dcf1 antibodies.

RESULTS

Deletion of Dcf1 resulted in decreased Aβ42 level and deposition, and rescued AMPA Receptor (GluA2) levels in the hippocampus of APP-PS1-AD mice. In Aβ42 AD Drosophila, the expression of Dcf1 in Aβ42 AD flies aggravated the formation and accumulation of senile plaques, significantly reduced its climbing ability and learning-memory. Data analysis from all 20 donors with and without AD patients aged between 80 and 90 indicated a high-level expression of Dcf1 in the temporal neocortex. Dcf1 contributed to Aβ aggregation by UV spectroscopy assay. Intracerebroventricular delivery of Dcf1 antibodies in the hippocampus reduced the area of senile plaques and reversed learning and memory deficits in APP-PS1-AD mice.

CONCLUSION

Dcf1 causes Aβ-plaque accumulation, inhibiting dcf1 expression could potentially offer therapeutic avenues.

摘要

背景

阿尔茨海默病(AD)是一种进行性神经退行性疾病。AD 的病理学之一是淀粉样β(Aβ)的积累形成老年斑,导致认知能力下降和学习记忆缺乏。然而,导致 Aβ聚集的原因尚不清楚。树突细胞因子 1(Dcf1)在 AD 患者的内嗅皮层神经元和神经纤维缠结中表达较高。

目的

我们的目标是研究 Dcf1 对 AD 发展中 Aβ聚集和记忆缺陷的影响。

方法

使用小鼠和果蝇 AD 模型来测试 Aβ的表达和聚集、老年斑形成以及认知行为的病理变化,在 dcf1 敲除和表达期间。最后,我们通过脑室内给予 Dcf1 抗体探索了可能的药物靶点效应。

结果

Dcf1 的缺失导致 APP-PS1-AD 小鼠海马中 Aβ42 水平和沉积减少,并且 AMPA 受体(GluA2)水平得到恢复。在 Aβ42 AD 果蝇中,Dcf1 在 Aβ42 AD 果蝇中的表达加剧了老年斑的形成和积累,显著降低了其攀爬能力和学习记忆。对 20 名年龄在 80 至 90 岁之间的 AD 患者和无 AD 患者的数据分析表明,Dcf1 在颞叶皮质中有高水平表达。UV 光谱测定法表明 Dcf1 有助于 Aβ聚集。脑室内给予 Dcf1 抗体可减少海马中的老年斑面积,并逆转 APP-PS1-AD 小鼠的学习和记忆缺陷。

结论

Dcf1 导致 Aβ 斑块堆积,抑制 dcf1 表达可能提供治疗途径。

相似文献

1
Deletion of Dcf1 Reduces Amyloid-β Aggregation and Mitigates Memory Deficits.Dcf1 缺失可减少淀粉样β 聚集并减轻记忆缺陷。
J Alzheimers Dis. 2021;81(3):1181-1194. doi: 10.3233/JAD-200619.
2
Dcf1 alleviates C99-mediated deficits in drosophila by reducing the cleavage of C99.Dcf1 通过减少 C99 的切割来减轻果蝇中 C99 介导的缺陷。
Biochem Biophys Res Commun. 2020 Sep 17;530(2):410-417. doi: 10.1016/j.bbrc.2020.05.063. Epub 2020 Jun 12.
3
Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.脑内接种人 A53T α-突触核蛋白可减少阿尔茨海默病 APP/PS1 转基因小鼠的空间记忆下降和淀粉样β聚集。
Brain Res Bull. 2018 Oct;143:116-122. doi: 10.1016/j.brainresbull.2018.10.003. Epub 2018 Oct 24.
4
Triptolide Rescues Spatial Memory Deficits and Amyloid-β Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.雷公藤甲素可挽救APP/PS1转基因小鼠的空间记忆缺陷和淀粉样β蛋白聚集,并伴有炎症反应和丝裂原活化蛋白激酶活性的抑制。
Curr Alzheimer Res. 2016;13(3):288-96. doi: 10.2174/156720501303160217122803.
5
Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.淀粉样β蛋白沉积与APP/PS1小鼠海马葡萄糖代谢降低及空间记忆损伤有关。
J Neuropathol Exp Neurol. 2004 May;63(5):418-28. doi: 10.1093/jnen/63.5.418.
6
Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.雄性 APP/PS1 小鼠海马 AD 病理学、肌动蛋白重塑蛋白与空间记忆行为的年龄相关性变化。
Behav Brain Res. 2019 Dec 30;376:112182. doi: 10.1016/j.bbr.2019.112182. Epub 2019 Aug 28.
7
CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.CART 通过上调β-淀粉样蛋白代谢相关酶减轻 APP/PS1 小鼠记忆缺陷中的氧化应激和 DNA 损伤。
Mol Med Rep. 2021 Apr;23(4). doi: 10.3892/mmr.2021.11919. Epub 2021 Feb 19.
8
Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.在阿尔茨海默病动物模型中,钙结合蛋白缺失神经元内的细胞内淀粉样β 积累导致淀粉样β 斑块形成。
J Alzheimers Dis. 2012;29(3):615-28. doi: 10.3233/JAD-2011-111778.
9
Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.小鼠淀粉样β蛋白在人APP/PS1双转基因和单转基因阿尔茨海默病模型小鼠中的沉积。
Neurobiol Dis. 2006 Sep;23(3):653-62. doi: 10.1016/j.nbd.2006.05.010. Epub 2006 Jul 10.
10
SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.SEN1500是一种新型口服淀粉样β蛋白聚集抑制剂,可减轻阿尔茨海默病小鼠模型的脑部病变。
Neurosci Lett. 2017 Nov 1;660:96-102. doi: 10.1016/j.neulet.2017.09.028. Epub 2017 Sep 14.

引用本文的文献

1
TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.跨膜蛋白59(TMEM59)缺乏激活伴侣介导的自噬并改善tau蛋白病模型小鼠的疾病样病理变化。
Alzheimers Dement. 2025 Jun;21(6):e70369. doi: 10.1002/alz.70369.